These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32583001)

  • 1. IGF‑IR promotes clonal cell proliferation in myelodysplastic syndromes via inhibition of the MAPK pathway.
    He Q; Zheng Q; Xu F; Shi W; Guo J; Zhang Z; Zhao S; Li X; Chang C
    Oncol Rep; 2020 Sep; 44(3):1094-1104. PubMed ID: 32583001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I insulin-like growth factor receptor over-expression induces proliferation and anti-apoptotic signaling in a three-dimensional culture model of breast epithelial cells.
    Yanochko GM; Eckhart W
    Breast Cancer Res; 2006; 8(2):R18. PubMed ID: 16584539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells.
    Strömberg T; Feng X; Delforoush M; Berglund M; Lin Y; Axelson M; Larsson O; Georgii-Hemming P; Lennartsson J; Enblad G
    Med Oncol; 2015 Jul; 32(7):188. PubMed ID: 26021470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the insulin-like growth factor I receptor by epigallocatechin gallate blocks proliferation and induces the death of Ewing tumor cells.
    Kang HG; Jenabi JM; Liu XF; Reynolds CP; Triche TJ; Sorensen PH
    Mol Cancer Ther; 2010 May; 9(5):1396-407. PubMed ID: 20423994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of Bone Marrow Clonal Cells from Patients with Myelodysplastic Syndrome via IGF-IR.
    He Q; Chang CK; Xu F; Zhang QX; Shi WH; Li X
    PLoS One; 2015; 10(10):e0140372. PubMed ID: 26469401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Picropodophyllin inhibits type I endometrial cancer cell proliferation via disruption of the PI3K/Akt pathway.
    Dong L; Du M; Lv Q
    Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):753-760. PubMed ID: 31168597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal expression of insulin-like growth factor-I receptor in hepatoma tissue and its inhibition to promote apoptosis of tumor cells.
    Dong Z; Yao M; Wang L; Yan X; Gu X; Shi Y; Yao N; Qiu L; Wu W; Yao D
    Tumour Biol; 2013 Dec; 34(6):3397-405. PubMed ID: 23797814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling.
    Razuvaev A; Henderson B; Girnita L; Larsson O; Axelson M; Hedin U; Roy J
    J Vasc Surg; 2007 Jul; 46(1):108-15. PubMed ID: 17606126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells.
    Strömberg T; Ekman S; Girnita L; Dimberg LY; Larsson O; Axelson M; Lennartsson J; Hellman U; Carlson K; Osterborg A; Vanderkerken K; Nilsson K; Jernberg-Wiklund H
    Blood; 2006 Jan; 107(2):669-78. PubMed ID: 16166596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HDAC inhibitor LBH589 enhances the antimyeloma effects of the IGF-1RTK inhibitor picropodophyllin.
    Lemaire M; Fristedt C; Agarwal P; Menu E; Van Valckenborgh E; De Bruyne E; Österborg A; Atadja P; Larsson O; Axelson M; Van Camp B; Jernberg-Wiklund H; Vanderkerken K
    Clin Cancer Res; 2012 Apr; 18(8):2230-9. PubMed ID: 22392915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cetuximab-induced insulin-like growth factor receptor I activation mediates cetuximab resistance in gastric cancer cells.
    Li X; Xu L; Li H; Zhao L; Luo Y; Zhu Z; Liu Y; Qu X
    Mol Med Rep; 2015 Jun; 11(6):4547-54. PubMed ID: 25625229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of inhibited IGF-IR expression on proliferation and apoptosis of human hepatocellular carcinoma cell lines].
    Yao NH; Yao DF; Dong ZZ; Yan XD; Chen J; Yao M; Wang L; Yan MJ
    Zhonghua Gan Zang Bing Za Zhi; 2013 May; 21(5):376-80. PubMed ID: 24025141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of HERG K
    Lu L; Du W; Liu W; Guo D; He X; Li H
    Hematology; 2016 Dec; 21(10):583-592. PubMed ID: 27077769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of
    Jiang M; Chen Y; Deng L; Luo X; Wang L; Liu L
    DNA Cell Biol; 2019 May; 38(5):476-484. PubMed ID: 30835546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-1 receptor inhibition by picropodophyllin in medulloblastoma.
    Ohshima-Hosoyama S; Hosoyama T; Nelon LD; Keller C
    Biochem Biophys Res Commun; 2010 Sep; 399(4):727-32. PubMed ID: 20692232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Picropodophyllin inhibits the growth of Ewing's sarcoma cells through the insulin‑like growth factor‑1 receptor/Akt signaling pathway.
    Wu YT; Wang BJ; Miao SW; Gao JJ
    Mol Med Rep; 2015 Nov; 12(5):7045-50. PubMed ID: 26323364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The type I insulin-like growth factor receptor highly expressed in clonal cells of myelodysplastic syndromes].
    He Q; Li X; Zhang Z; Zhang QX; Yang LP
    Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):744-7. PubMed ID: 22339909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the insulin-like growth factor-1 receptor by picropodophyllin for lung cancer chemoprevention.
    Zhang Q; Pan J; Lubet RA; Wang Y; You M
    Mol Carcinog; 2015 Jun; 54 Suppl 1():E129-37. PubMed ID: 25163779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dsh homolog DVL3 mediates resistance to IGFIR inhibition by regulating IGF-RAS signaling.
    Gao S; Bajrami I; Verrill C; Kigozi A; Ouaret D; Aleksic T; Asher R; Han C; Allen P; Bailey D; Feller S; Kashima T; Athanasou N; Blay JY; Schmitz S; Machiels JP; Upile N; Jones TM; Thalmann G; Ashraf SQ; Wilding JL; Bodmer WF; Middleton MR; Ashworth A; Lord CJ; Macaulay VM
    Cancer Res; 2014 Oct; 74(20):5866-77. PubMed ID: 25168481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-targeting insulin-like growth factor I receptor and HER2: dramatic effects of HER2 inhibitors on nonoverexpressing breast cancer.
    Chakraborty AK; Liang K; DiGiovanna MP
    Cancer Res; 2008 Mar; 68(5):1538-45. PubMed ID: 18316619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.